202 related articles for article (PubMed ID: 37305383)
21. Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
Cao HZ; Yang WT; Zheng PS
BMC Cancer; 2022 May; 22(1):521. PubMed ID: 35534815
[TBL] [Abstract][Full Text] [Related]
22. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
[TBL] [Abstract][Full Text] [Related]
23. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo.
Zhang H; Chen D; Ringler J; Chen W; Cui QC; Ethier SP; Dou QP; Wu G
Cancer Res; 2010 May; 70(10):3996-4004. PubMed ID: 20424113
[TBL] [Abstract][Full Text] [Related]
24. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint.
Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z
Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028
[TBL] [Abstract][Full Text] [Related]
25. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
[TBL] [Abstract][Full Text] [Related]
26. Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu
Hu H; Cui L; Lu J; Wei K; Wei J; Li S; Zou C; Chen T
Cancer Med; 2020 Sep; 9(18):6791-6801. PubMed ID: 32750218
[TBL] [Abstract][Full Text] [Related]
27. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ
PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479
[TBL] [Abstract][Full Text] [Related]
28. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
[TBL] [Abstract][Full Text] [Related]
29. Combination of the cuproptosis inducer disulfiram and anti‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway.
Li P; Sun Q; Bai S; Wang H; Zhao L
Int J Mol Med; 2024 Feb; 53(2):. PubMed ID: 38186308
[TBL] [Abstract][Full Text] [Related]
30. An anti-alcoholism drug, disulfiram and copper complex improves radio-resistance of tumor-initiating cells in esophageal squamous cell carcinoma.
Qian L; Murakami K; Toyozumi T; Matsumoto Y; Otsuka R; Sekino N; Endo S; Kinoshita K; Sasaki T; Matsubara H
Esophagus; 2023 Jan; 20(1):134-142. PubMed ID: 36121574
[TBL] [Abstract][Full Text] [Related]
31. Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
Wang K; Michelakos T; Wang B; Shang Z; DeLeo AB; Duan Z; Hornicek FJ; Schwab JH; Wang X
Cancer Lett; 2021 May; 505():37-48. PubMed ID: 33582212
[TBL] [Abstract][Full Text] [Related]
32. Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma.
Morrison BW; Doudican NA; Patel KR; Orlow SJ
Melanoma Res; 2010 Feb; 20(1):11-20. PubMed ID: 19966593
[TBL] [Abstract][Full Text] [Related]
33. The combination of disulfiram and copper for cancer treatment.
Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W
Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854
[TBL] [Abstract][Full Text] [Related]
34. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions.
Yang Y; Zhang K; Wang Y; Li M; Sun X; Liang Z; Wang L; Chen L; Yang H; Zhu L
Scanning; 2016 Nov; 38(6):825-836. PubMed ID: 27353661
[TBL] [Abstract][Full Text] [Related]
35. Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper.
Falls-Hubert KC; Butler AL; Gui K; Anderson M; Li M; Stolwijk JM; Rodman SN; Solst SR; Tomanek-Chalkley A; Searby CC; Sheffield VC; Sandfort V; Schmidt H; McCormick ML; Wels BR; Allen BG; Buettner GR; Schultz MK; Spitz DR
Free Radic Biol Med; 2020 Apr; 150():1-11. PubMed ID: 32032663
[TBL] [Abstract][Full Text] [Related]
36. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells.
Cen D; Brayton D; Shahandeh B; Meyskens FL; Farmer PJ
J Med Chem; 2004 Dec; 47(27):6914-20. PubMed ID: 15615540
[TBL] [Abstract][Full Text] [Related]
37. Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms.
Sun F; Wang H; Nie J; Hong B
Anticancer Agents Med Chem; 2022; 22(17):2920-2926. PubMed ID: 35430981
[TBL] [Abstract][Full Text] [Related]
38. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies.
Conticello C; Martinetti D; Adamo L; Buccheri S; Giuffrida R; Parrinello N; Lombardo L; Anastasi G; Amato G; Cavalli M; Chiarenza A; De Maria R; Giustolisi R; Gulisano M; Di Raimondo F
Int J Cancer; 2012 Nov; 131(9):2197-203. PubMed ID: 22322883
[TBL] [Abstract][Full Text] [Related]
39. Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions.
Jiao Y; Hannafon BN; Zhang RR; Fung KM; Ding WQ
Oncotarget; 2017 Mar; 8(11):17908-17920. PubMed ID: 28107189
[TBL] [Abstract][Full Text] [Related]
40. The promising antitumour drug disulfiram inhibits viability and induces apoptosis in cardiomyocytes.
Li Y; Shen J; Fang M; Huang X; Yan H; Jin Y; Li J; Li X
Biomed Pharmacother; 2018 Dec; 108():1062-1069. PubMed ID: 30372806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
